Brief: Argenica Therapeutics Successfully Completes A$12.0M Placement
12/04/2024 02:26
April 12 (Reuters) - Argenica Therapeutics Ltd AGN.AX :
* SUCCESSFULLY COMPLETES A$12.0M PLACEMENT
* ISSUE PRICE OF A$0.52 PER SHARE
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M